T. Kainu

发表

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

E. Gillanders, D. Stephan, H. Grönberg, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Androgen Receptor Gene Alterations in Finnish Male Breast Cancer

A. Auvinen, O. Kallioniemi, P. Koivisto, 2004, Breast Cancer Research and Treatment.

Localization of the peroxisome proliferator-activated receptor in the brain.

J. Gustafsson, M. Pelto-huikko, A. Wikström, 1994, Neuroreport.

Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene.

J. Gustafsson, M. Pelto-huikko, C. Köhler, 1996, Molecular pharmacology.

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

Jaana M. Hartikainen, J. Kere, E. Gillanders, 2000, European Journal of Human Genetics.

The dioxin receptor and its nuclear translocator (Arnt) in the rat brain

J. Gustafsson, M. Pelto-huikko, T. Kainu, 1995, Neuroreport.

Genome-wide scanning for linkage in Finnish breast cancer families

E. Gillanders, J. Trent, O. Kallioniemi, 2004, European Journal of Human Genetics.

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

O. Kallioniemi, H. Nevanlinna, H. Eerola, 2001, British Journal of Cancer.

Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation

J. Trent, D. Stephan, E. Hoffman, 2004, Neurology.

Response: Re: Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

O. Kallioniemi, H. Nevanlinna, H. Eerola, 2001 .

Identification of a novel member of the nuclear receptor superfamily which is closely related to Rev-ErbA.

J. Gustafsson, M. Pelto-huikko, T. Kainu, 1994, Biochemical and biophysical research communications.

Induction of multiple immediate early genes in rat hypothalamic paraventricular nucleus after stress.

J. Kononen, T. Kainu, M. Pelto-Huikko, 1994, Brain research. Molecular brain research.

Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.

K Holli, O. Kallioniemi, H. Nevanlinna, 2000, Journal of the National Cancer Institute.

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.

O. Kallioniemi, B. Ward, H. Nevanlinna, 1997, Human molecular genetics.

BRCA2 mutations in 154 finnish male breast cancer patients.

Anssi Auvinen, A. Auvinen, K. Waltering, 2004, Neoplasia.

Oncogenes and Tumor Suppressor Genes in Prostate Cancer 37 CHROMOSOMAL ABNORMALITIES IN PROSTATE CANCER CELLS

W. Isaacs, T. Kainu, 2005 .

Oncogenes and tumor suppressor genes in prostate cancer.

W. Isaacs, T. Kainu, 2001, Epidemiologic reviews.

Evidence for a prostate cancer susceptibility locus on the X chromosome.

F. Collins, D. Schaid, J. Carpten, 1998, Nature Genetics.

Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families

J. Kere, O. Kallioniemi, R. Barkardottir, 2001, European Journal of Human Genetics.

Genome‐wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25‐26

E. Gillanders, J. Trent, J. Schleutker, 2003, The Prostate.

A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes

Heli Nevanlinna, Therese Sandberg, Dietrich A. Stephan, 2002, Human Genetics.

Genome-wide scanning for linkage in Finnish breast cancer families

E. Gillanders, J. Trent, O. Kallioniemi, 2004, European Journal of Human Genetics.

A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region

Tanya M. Teslovich, J. Carpten, E. Gillanders, 2005, Human Genetics.

Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization.

Borg A, J. Kononen, J. Isola, 1996, Cancer research.

Evidence for a Prostate Cancer Susceptibility Locus on the X Chromosome

F. Collins, D. Schaid, J. Carpten, 1999 .

Fos and jun in rat central amygdaloid nucleus and paraventricular nucleus after stress.

T. Hökfelt, S. Ceccatelli, M. Pelto-huikko, 1992, Neuroreport.

A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.

J. Carpten, E. Gillanders, D. Stephan, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Co-localization of peptide-like immunoreactivities with glucocorticoid receptor- and Fos-like immunoreactivities in the rat parabrachial nucleus

J. Gustafsson, M. Pelto-huikko, T. Kainu, 1993, Brain Research.

Localization and ontogeny of the orphan receptor OR-1 in the rat brain

J. Kononen, J. Gustafsson, M. Pelto-huikko, 2007, Journal of Molecular Neuroscience.

Somatic genetic alterations in BRCA2‐associated and sporadic male breast cancer

O. Kallioniemi, N. Loman, O. Johannsson, 1999, Genes, chromosomes & cancer.

BENIGN AND MALIGNANT NEOPLASMS OF PROSTATE Evidence for a Prostate Cancer Susceptibility Locus on the X Chromosome

F. Collins, D. Schaid, J. Carpten, 1999 .

Localization of the Rev-ErbA orphan receptors in the brain

J. Gustafsson, M. Pelto-huikko, T. Kainu, 1996, Brain Research.